Huang Andong
SEC insider (Form 3/4/5 filer). CIK 0001815678. Director at Outlook Therapeutics, Inc. (OTLK). 5 reported Form 4/5 transactions since Sep 2024; latest on Oct 3, 2025. Located in ISELIN, NJ.
Companies Huang Andong has filed insider reports for
- Outlook Therapeutics, Inc. (OTLK): Director
Huang Andong
CIK: 0001815678
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Outlook Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 3, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
53.3K shares- - Oct 1, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
286.7K shares- - Oct 3, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
11K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
56.6K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
23.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 3, 2025 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 53,316 | - | - | Direct |
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 286,734 | - | - | Direct |
| Oct 3, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 10,984 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 56,636 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 23,509 | - | - | Direct |
1-5 of 5 transactions